Company Overview and News
Bursa Malaysia closed mixed today with the key index rebounded strongly from an earlier downtrend to close at almost four-year high. — Picture by Azneal IshakKUALA LUMPUR, April 12 — Bursa Malaysia closed mixed today with the key index rebounded strongly from an earlier downtrend to close at almost four-year high, lifted by late buying interests in selected blue-chips.
KUALA LUMPUR, April 11 — Bursa Malaysia finished strongly for the third consecutive day, spurred by buying in small capitalisation stocks and selected blue chips, thanks to the bullish market sentiment.
KUALA LUMPUR, April 11 — Bursa Malaysia remained higher at mid-morning today on persistent buying in small capitalisation and selected blue chips.
A view of the bursa stock market exchange board in RHB Investment Bank in Kuala Lumpur February 6, 2018. — Picture Ahmad ZamzahuriKUALA LUMPUR, April 9 — Bursa Malaysia closed broadly higher today in line with the gains on regional peers as risk appetite improved on the back of the ease in US-China trade war tension.
KUALA LUMPUR, April 9 — Bursa Malaysia opened mixed this morning amid cautious trading and ahead of the 14 General Elections.
Shares on Bursa Malaysia closed mixed on April 6, 2018. — Bernama picKUALA LUMPUR, April 6 — Shares on Bursa Malaysia closed mixed as last-minute buying in selected heavyweights helped lift the benchmark index.
KUALA LUMPUR, April 6 — Shares on Bursa Malaysia opened higher but declined thereafter on profit-taking, following yesterday's gains.
KUALA LUMPUR, April 2 — Shares on Bursa Malaysia were slightly higher in the early session today, as trader took cue from gains on Asian stocks.
KUALA LUMPUR, March 7 — Bursa Malaysia ended the morning session in the red on weak buying sentiment and due to renewed fears of a trade war led by the United States, following the resignation of a key free trade advocate at the White House.
Market breadth was slightly negative as losers led gainers 391 to 363, while 396 counters remained unchanged, 733 untraded and 52 others suspended. — Picture Ahmad ZamzahuriKUALA LUMPUR, Feb 27 — Bursa Malaysia remained higher at mid-morning today and amid persistent buying interest in selected blue-chip finance stocks and heavyweights.
On the broader market, gainers led losers 252 to 135, while 213 counters were unchanged, 1,283 untraded and 52 others suspended. — Picture Ahmad ZamzahuriKUALA LUMPUR, Feb 27 — Bursa Malaysia opened higher today on the back of positive investor sentiment.
According to executive director Raymond Teo Kiew Leong, Borneo Oil’s franchised division targets to set up 40 “Broasted by SugarBun” kiosks this year under the new concept. Half or 20 of the proposed kiosks will be in Sabah, 15 in Peninsular Malaysia and five in Sarawak.(Filepic shows Teo in suit talking to some of the staff in one of the outlets)
KUALA LUMPUR, Feb 12 — Bursa Malaysia stayed higher at mid-morning on continued buying interest in selected heavyweights led by Axiata, CIMB and Maxis.
KUALA LUMPUR, Feb 9 — Bursa Malaysia ended the morning session in the red territory across-the-board today on bearish sentiment, tracking the global selloffs following another day of Wall Street losses, dealers said.
KUALA LUMPUR, Feb 9 — Bursa Malaysia remained lower across-the-board at mid-morning today, tracking its regional peers on the back of the Wall Street drop overnight, dealers said.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...